MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Beauty

Maypharm

More Like This

PR Newswire associated0

Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration

PR Newswire associated0

BioQ Debuts at in‑cosmetics Global, Showcasing China's Advancing Strength in Ingredient Innovation

PR Newswire associated0

Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™

PR Newswire associated0

MAYPHARM CO., LTD. Launches SKINCOLLA: The World's First Recombinant Human Collagen Filler for Superior Skin Rejuvenation

PR Newswire associated0

Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio